Government Affairs
Refine Search
Pharmaceutical
The majority of General Practitioners in the UK now favor the Conservative Party's health policy, despite opposing Tory plans to impose commissioning responsibility on the profession, according to a poll for the UK-based GP newspaper 15 January 2010
Generics
US Federal Trade Commission Chairman Jon Leibowitz and key members of Congress, including Representative Chris Van Hollen, Chairman Bobby Rush and Representative Mary Jo Kilroy, renewed their call for legislation that would put an end to anticompetitive patent settlements, which drugmakers have been using to keep less-expensive copy medicines off the market and charge consumers billions of dollars a year in higher drug prices. 14 January 2010
Pharmaceutical
Kenya's pharmaceutical industry is on a rebound, riding on the back of increased expenditure in healthcare and general economic growth over the years, reports the local Business Daily newspaper. 13 January 2010
Biotechnology
At the end of 2009, the Belgian Central Council of the Economy (the CEC) attracted attention to the country's loss of competitiveness in recent years vis-a-vis other European Union nations. In this context, the employers federation, the FEB, believes that the essential thing to focus on in 2010 is the competitiveness of companies, arguing that employment is paramount for the nation's prosperity, but new employment is only possible if Belgian companies are more competitive than their foreign competitors. 13 January 2010
Pharmaceutical
The US Food and Drug Administration yesterday unveiled the first phase of its Transparency Initiative, which is designed to explain the agency's operations, how it makes decisions, and the drug approval process. 13 January 2010
Biotechnology
After a decade of remarkable growth, total annual funding for biomedical research in the USA has decelerated and may have even fallen when adjusted for inflation. That is the conclusion of a study today published in the Journal of the American Medical Association. 13 January 2010
Pharmaceutical
A study from the USA's General Accountability Office, the investigational body of Congress, has revealed "extraordinary price increases" for 321 brand-name drugs, with prices jumping by 100% to 499% and, in a few cases, by over 1,000%. The number of drug price hikes more than doubled from 2000 to 2008, with most of these products maintaining their higher prices over time, the report found. 12 January 2010
Generics
Stepping up its investigations of the pharmaceutical industry, the European Commission confirmed this morning that, on the basis of European Union antitrust rules, it has addressed requests for information to certain pharmaceutical companies asking them to submit copies of their patent settlement agreements. 12 January 2010
Pharmaceutical
Following the police seizure in Bolivia of some 40 tonnes of adulterated drugs between last December and January this year, there has been a call for more severe penalties on such activities for the authorities in the country. 12 January 2010
Generics
Japanese health and finance ministers have accepted a proposal by the Korosho, the Council for Promoting Drug Industry Policies of the Ministry of Health, Labor and Welfare, to reduce the premium for the development of new, and the elimination of off-label use, of drugs to 80% and increase the across-the-board reduction rate for all long-listed drugs to 2.2% so as to mitigate the financial burden of the premium. 11 January 2010
Pharmaceutical
In line with recent moves by other European governments, notably in France and Germany, as well as European Parliament moves to debate the 'pandemic fiasco'(The Pharma Letter January 5), UK officials are in discussion with drugs giant GlaxoSmithKline over contracts for remaining doses of the H1N5 pandemic influenza vaccine. Options include selling surplus vaccine and donating it to poorer countries but a stockpile will remain in place, reported the public broadcaster, the BBC. 11 January 2010
Pharmaceutical
Health care reform in the USA will change, if not send shock waves through, virtually the entire field of health care law. That is the consensus of 24 health law practitioners from BNA's Health Law Reporter advisory board, in a survey conducted in December 2009. 11 January 2010
Generics
With India's capacity to manufacture medicines at competitive prices and drugs worth $80 million going off-patents soon, there is a big opportunity for investment in the drug manufacturing sector, Health Minister Ghulam Nabi Azad said on January 9, reported by the Business Standard, The Hindu and other local media. 11 January 2010
Pharmaceutical
Action against Australian plasma and vaccines producer CSL has continued to accelerate, since the US Federal Trade Commission blocked the firm's proposed $3.1 billion acquisition of the American firm Talecris Biotherapeutics last year on the basis of competition concerns and allegations of market manipulation, as CSL was already the second-largest blood-based medicines operator in the US market (The Pharma Letter June 9, 2009). 11 January 2010
Pharmaceutical
A drug safety review committee in Hong Kong last week unveiled a report, proposing that a dedicated office be set up to plan and direct the implementation of drug-safety measures, according to the Xinhua news agency. 11 January 2010
Biotechnology
Although drug developers are improving R&D efficiency, in part by terminating more unpromising drugs earlier in development, their continued success will depend on how well they partner with other firms at specific points on the development spectrum, according to the USA's Tufts Center for the Study of Drug Development. 8 January 2010
Biotechnology
The first three state-of-the-art manufacturing research centers ' including one impacting on biotechnology - funded under a new 70 million ($113 million) UK government investment will be based at Southampton, Loughborough and Brunel universities, to help UK businesses develop the technology products of the future and underpin manufacturing growth, Business Secretary Lord Peter Mandelson announced yesterday. 8 January 2010
Pharmaceutical
As part of its ongoing questioning of the activities of European pharmaceutical companies, which have, over the past included 'dawn raids' on their premises (The Pharma Letters passim), the European Commission has opened a formal antitrust investigation into Denmark-headquartered drugmaker Lundbeck to examine potential breaches of European Union rules on restrictive business practices and on the abuse of a dominant market position under Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU). 7 January 2010
Pharmaceutical
The Hellenic Association of Pharmaceutical Companies (SFEE) has collected and analysed all the available data relating to pharmaceutical debts of public hospitals due to its member-companies. The analysis resulted in a set of tables, which describe in detail the overall amount due per public hospital, as well as the average length of payment delay. 7 January 2010
Pharmaceutical
Speaker of the US House of Representatives Nancy Pelosi held a brief press availability with Chairman Charles Rangel, Chairman Henry Waxman, Chairman George Miller and Chairwoman Louise Slaughter following their meeting with President Barack Obama at the White House to discuss health care legislation and the reconciliation between the House and Senate versions of bills that have been passed in the respective Chambers (The Pharma Letters passim). 7 January 2010
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze